HIV PREVENTION, TREATMENT, CARE AND SUPPORT FOR PE

Purpose of this guide

The purpose of this publication is to provide guidance on implementing HIV, hepatitis C (HCV) and hepatitis B (HBV) programmes for people who use stimulant drugs and who are at risk of contracting these viruses. It aims to:

• Increase awareness of the needs and issues faced by the affected groups, including the intersectionality among different key populations
• Provide implementation guidance to help establish and expand access to core HIV and hepatitis prevention, treatment, care and support services

It is a global document that should be adapted according to the specific context, including the type of stimulant drug used (cocaine, ATS or NPS) and the key populations involved, which vary considerably according to regions.

The present guide proposes a package of core interventions adapted from existing international
guidance:

• WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users [7]
• WHO Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations – 2016 update [8]
• Implementing comprehensive HIV and HCV programmes with people who inject drugs: practical